Camurus AB (CAMX) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.060x

Based on the latest financial reports, Camurus AB (CAMX) has a cash flow conversion efficiency ratio of 0.060x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr255.43 Million ≈ $27.49 Million USD) by net assets (Skr4.24 Billion ≈ $455.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CAMX cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Camurus AB - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Camurus AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Camurus AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Camurus AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kimberly-Clark de México S. A. B. de C. V MX:KIMBERA	0.486x
Xiamen Amoytop Biotech Co Ltd SHG:688278	0.121x
Fermi Inc. NASDAQ:FRMI	0.073x
Multistrada Arah Sarana Tbk JK:MASA	0.131x
Hubei TKD Crystal Electn SHG:603738	0.015x
ATHENS INTERNATIONAL AIRPORT S. AT:AIA	N/A
Loomis AB ser. B ST:LOOMIS	0.098x
Beam Therapeutics Inc NASDAQ:BEAM	-0.110x

Annual Cash Flow Conversion Efficiency for Camurus AB (2012–2025)

The table below shows the annual cash flow conversion efficiency of Camurus AB from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see CAMX stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr4.24 Billion ≈ $455.80 Million	Skr869.30 Million ≈ $93.55 Million	0.205x	+74.02%
2024-12-31	Skr3.29 Billion ≈ $354.02 Million	Skr387.99 Million ≈ $41.75 Million	0.118x	-70.98%
2023-12-31	Skr1.49 Billion ≈ $160.67 Million	Skr606.88 Million ≈ $65.31 Million	0.406x	+299.53%
2022-12-31	Skr994.67 Million ≈ $107.04 Million	Skr101.20 Million ≈ $10.89 Million	0.102x	+160.22%
2021-12-31	Skr848.91 Million ≈ $91.36 Million	Skr-143.43 Million ≈ $-15.44 Million	-0.169x	+40.05%
2020-12-31	Skr847.44 Million ≈ $91.20 Million	Skr-238.83 Million ≈ $-25.70 Million	-0.282x	+55.98%
2019-12-31	Skr631.63 Million ≈ $67.97 Million	Skr-404.36 Million ≈ $-43.52 Million	-0.640x	+41.06%
2018-12-31	Skr252.32 Million ≈ $27.15 Million	Skr-274.08 Million ≈ $-29.50 Million	-1.086x	-105.94%
2017-12-31	Skr385.00 Million ≈ $41.43 Million	Skr-203.07 Million ≈ $-21.85 Million	-0.527x	-43.27%
2016-12-31	Skr564.42 Million ≈ $60.74 Million	Skr-207.79 Million ≈ $-22.36 Million	-0.368x	-4068.62%
2015-12-31	Skr640.56 Million ≈ $68.93 Million	Skr-5.66 Million ≈ $-608.78K	-0.009x	-101.57%
2014-12-31	Skr123.46 Million ≈ $13.29 Million	Skr69.43 Million ≈ $7.47 Million	0.562x	-82.74%
2013-12-31	Skr50.05 Million ≈ $5.39 Million	Skr163.06 Million ≈ $17.55 Million	3.258x	+429.67%
2012-12-31	Skr40.21 Million ≈ $4.33 Million	Skr24.73 Million ≈ $2.66 Million	0.615x	--

About Camurus AB

ST:CAMX Sweden Biotechnology

Market Cap

$3.33 Billion

Skr30.95 Billion SEK

Market Cap Rank

#4722 Global

#59 in Sweden

Share Price

Skr519.00

Change (1 day)

-2.63%

52-Week Range

Skr437.40 - Skr733.50

All Time High

Skr733.50